Unmet Need in Multiple Myeloma
The following content provides information on the critical unmet need for patients with multiple myeloma experiencing their first relapse
This multimedia content is made available for HCPs specializing in oncology for learning and information purposes only to address the need of the medical community to better understand investigational interventions and the physiology of disease
Dr Weisel on the Unmet Need in 2L Multiple Myeloma
Hear Dr Katja Weisel discuss unmet need for patients with multiple myeloma experiencing their first relapse at the COMy 2023 symposium
Dr Popat on the Unmet Need in 2L Multiple Myeloma
Hear Dr Rakesh Popat discuss unmet need for patients with multiple myeloma in a post MAIA regimen (DRd) setting at the EHA2023 symposium
Dr Richardson on the Unmet Need in 2L Multiple Myeloma
Hear Dr Paul Richardson discuss unmet need for novel 2L+ options in an evolving treatment landscape at a MMy Conversations webinar
Dr Manier on the Clinical Outcomes of Retreatment with Standard of Care
Hear Dr Saloman Manier discuss the clinical impact of re-treating with the same therapy class in RRMM at a MMy Conversations webinar
Dr. Ocio on the Dynamic Landscape in Multiple Myeloma
Hear Dr Enrique Ocio discuss the evolving clinical landscape in multiple myeloma at the EHA 2022 symposium
Dr. Palumbo on Selecting Optimal MM Treatment for Patients
Hear Dr Antonio Palumbo discuss key patient considerations and factors for selecting the appropriate treatment regimen for patients with multiple myeloma at the COMy 2022 symposium
Dr. Richardson on the Dynamic Landscape in Multiple Myeloma
Hear Dr Paul Richardson discuss the evolving clinical landscape in multiple myeloma at the COMy 2022 symposium
SE-GBL-ON-WCNT-200001 | June 2023